Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 2
- 4
- 4
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myelomaAnnals of Hematology, 2018, 97 (5), pp.831-837. ⟨10.1007/s00277-018-3236-6⟩
Journal articles
hal-01728968v1
|
|||
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN studyBlood, 2014, 124 (14), pp.2196--2202. ⟨10.1182/blood-2014-07-586610⟩
Journal articles
hal-01147035v1
|
|||
|
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaLeukemia, 2019, 33 (9), pp.2324-2330. ⟨10.1038/s41375-019-0452-6⟩
Journal articles
hal-02190723v1
|
||
Long-term outcome of monoclonal (type 1) cryoglobulinemia.American Journal of Hematology, 2014, 89 (2), pp.156-61. ⟨10.1002/ajh.23608⟩
Journal articles
hal-00966891v1
|